Healthy

1807
Pipeline Programs
30
Companies
50
Clinical Trials
11 recruiting
35
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1713
4
13
1
12
64
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
15083%
Peptide
158%
Monoclonal Antibody
127%
Vaccine
21%
RNA Therapeutic
11%
+ 1666 programs with unclassified modality

On Market (35)

Approved therapies currently available

U
AEROLATEApproved
theophylline
Unknown Company
oral1986
U
AEROLATE IIIApproved
theophylline
Unknown Company
oral1986
U
AEROLATE JRApproved
theophylline
Unknown Company
oral1986
U
AEROLATE SRApproved
theophylline
Unknown Company
oral1986
U
BENICARApproved
olmesartan medoxomil
Unknown Company
oral2002
U
CEFDINIRApproved
cefdinir
Unknown Company
Cephalosporin Antibacterial [EPC]oral2021
U
CHOLESTYRAMINEApproved
cholestyramine
Unknown Company
Bile Acid Sequestrant [EPC]oral1996
Abbott
DEPAKOTE CPApproved
divalproex sodium
Abbott
oral1990
J&
DURAGESIC-50Approved
fentanyl
Johnson & Johnson
transdermal1990
U
ECONOPREDApproved
prednisolone acetate
Unknown Company
ophthalmic1973
U
ELIXOMINApproved
theophylline
Unknown Company
oral
U
ESOMEPRAZOLE MAGNESIUMApproved
esomeprazole
Unknown Company
Proton Pump Inhibitor [EPC]oral2024
Rhythm Pharmaceuticals
IMCIVREEApproved
setmelanotide
Rhythm Pharmaceuticals
Melanocortin 4 Receptor Agonist [EPC]subcutaneous2020
Eli Lilly and Company
INLURIYOApproved
imlunestrant
Eli Lilly and Company
Estrogen Receptor Antagonist [EPC]oral2025
J&
INVOKAMETApproved
canagliflozin and metformin hydrochloride
Johnson & Johnson
oral2014
J&
INVOKANAApproved
canagliflozin
Johnson & Johnson
oral2013
U
LANOPHYLLINApproved
theophylline
Unknown Company
oral1976
Boehringer Ingelheim
MICARDISApproved
telmisartan
Boehringer Ingelheim
Angiotensin 2 Receptor Blocker [EPC]oral1998
U
OLMESARTAN MEDOXOMILApproved
olmesartan medoxomil
Unknown Company
oral2023
Novartis
OMNIPREDApproved
prednisolone acetate
Novartis
ophthalmic1973
U
PREVALITEApproved
cholestyramine
Unknown Company
Bile Acid Sequestrant [EPC]oral1996
U
SOMOPHYLLIN-CRTApproved
theophylline
Unknown Company
oral1997
U
SOMOPHYLLIN-TApproved
theophylline
Unknown Company
oral
U
T-PHYLApproved
theophylline
Unknown Company
oral1983
U
TELMISARTANApproved
telmisartan
Unknown Company
Angiotensin 2 Receptor Blocker [EPC]oral2015
U
THEOBIDApproved
theophylline
Unknown Company
oral1985
U
THEOBID JR.Approved
theophylline
Unknown Company
oral1985
U
THEOCLEAR L.A.-130Approved
theophylline
Unknown Company
oral
U
THEOCLEAR L.A.-260Approved
theophylline
Unknown Company
oral
U
THEOLAIR-SRApproved
theophylline
Unknown Company
oral1987
U
THEOLIXIRApproved
theophylline
Unknown Company
oral
U
THEOPHYLLINEApproved
theophylline
Unknown Company
Methylxanthine [EPC]oral2023
U
THEOPHYLLINE-SRApproved
theophylline
Unknown Company
oral1986
J&
XARELTOApproved
rivaroxaban
Johnson & Johnson
oral2011
Bayer
YASMINApproved
drospirenone and ethinyl estradiol
Bayer
oral-282001

Competitive Landscape

162 companies ranked by most advanced pipeline stage

Boehringer Ingelheim
748
7
2
3
AggrenoxPhase 41 trial
Meloxicam - lowPhase 41 trial
TelmisartanPhase 4Small Molecule1 trial
Gingko bilobaPhase 31 trial
Pharmaton PHL 00747 soft gelatine capsulesPhase 31 trial
+755 more programs
Active Trials
NCT02177305Completed48
NCT02106923Completed72Est. Jul 2014
NCT02597998Completed6Est. Dec 2015
+757 more trials
Pfizer
158 programs
147
1
7
Alivium®Phase 41 trial
Cymbalta CapsulesPhase 41 trial
Cymbalta capsulePhase 41 trial
Prevenar and MeningitecPhase 41 trial
Ultracet TabletsPhase 41 trial
+153 more programs
Active Trials
NCT00508950Completed152Est. Jun 2016
NCT00913406Completed232Est. May 2006
NCT01677065Completed14Est. Oct 2012
+201 more trials
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
60 programs
56
1
1
LY3549492Phase 21 trial
5 mg empagliflozin/850 mg metformin FDCPhase 1
AbemaciclibPhase 1Small Molecule1 trial
Abemaciclib CapsulesPhase 11 trial
Biochaperone insulin lispro 0.1 U/kgPhase 11 trial
+55 more programs
Active Trials
NCT02413203Completed20Est. Nov 2015
NCT06516913Completed32Est. Sep 2024
NCT04682184Completed21Est. Mar 2021
+74 more trials
AstraZeneca
43 programs
39
1
EsomeprazolePhase 4Small Molecule1 trial
AZD0530Phase 14 trials
AZD0585Phase 11 trial
AZD0837Phase 15 trials
AZD1305Phase 15 trials
+38 more programs
Active Trials
NCT00860821Completed20Est. Oct 2009
NCT01308372Completed9,246Est. Oct 2011
NCT06157255Completed8Est. May 2024
+70 more trials
J&
16
5
Colgate Cavity Protection ToothpastePhase 41 trial
Colgate Cavity Protection ToothpastePhase 41 trial
LISTERINE COOL MINT Antiseptic MouthwashPhase 41 trial
Listerine Clinical Solutions Teeth StrengthPhase 41 trial
Listerine Experimental MouthwashPhase 41 trial
+21 more programs
Active Trials
NCT06798441Completed161Est. Feb 2025
NCT00707291Completed61Est. Jun 2011
NCT00916565Completed139
+36 more trials
Novartis
NovartisBASEL, Switzerland
19 programs
18
1
Prednisolone acetatePhase 41 trial
AEB071Phase 11 trial
AEB071Phase 11 trial
AHT956Phase 11 trial
AQW051Phase 11 trial
+14 more programs
Active Trials
NCT00409929Completed16
NCT00416546Completed96Est. Oct 2007
NCT00410228Completed42
+17 more trials
Abbott
14 programs
4
1
1
2
cefdinirPhase 41 trial
divalproex sodiumPhase 41 trial
Milk based formula APhase 2/31 trial
Alternate protein infant formulaPhase 21 trial
ABT-126Phase 11 trial
+9 more programs
Active Trials
NCT00718042Completed41,862Est. Sep 2009
NCT04862065Completed16,388Est. Aug 2021
NCT03285295Completed106,881Est. Jun 2018
+16 more trials
Takeda
14 programs
13
1
theophyllinePhase 41 trial
DeferitazolePhase 1Small Molecule1 trial
KetaminePhase 1
Metronidazole + MMX Mesalazine/mesalamine placeboPhase 11 trial
MidazolamPhase 13 trials
+9 more programs
Active Trials
NCT02065401Withdrawn0Est. Mar 2014
NCT01418365Completed30Est. Oct 2011
NCT03336645Completed25Est. Aug 2019
+13 more trials
E
13 programs
11
1
1
Perampanel 6 MGPhase 41 trial
Rabeprazole sodium, 5 mg TabletsPhase 21 trial
E2022Phase 11 trial
E2022- Current Formula TapePhase 11 trial
E2609Phase 11 trial
+8 more programs
Active Trials
NCT01450839Completed16Est. Feb 2012
NCT02042729Completed34Est. Dec 2012
NCT01511783Completed50Est. Nov 2012
+10 more trials
Bristol Myers Squibb
12 programs
8
1
1
tenofovir, emtricitabine and efavirenz fixed dose tabletPhase 41 trial
INX-08189 50 mg QD X 5 daysPhase 1/21 trial
BMS-931699Phase 11 trial
BMS-986141 Form A TabletPhase 11 trial
ClopidogrelPhase 1
+7 more programs
Active Trials
NCT01031862Completed12Est. Jun 2010
NCT01732848Completed113Est. Jun 2014
NCT03058822Terminated5Est. Mar 2017
+5 more trials
Bayer
7 programs
5
1
1
YASMIN(Yasmin)Phase 35 trials
DexpanthenolPhase 11 trial
ODM-201 300 mg tabletPhase 11 trial
VatalinibPhase 1Small Molecule1 trial
[14C]-NT-814Phase 11 trial
+2 more programs
Active Trials
NCT00313118Withdrawn0Est. Dec 2016
NCT00885937Completed33Est. May 2009
NCT02418650Completed12Est. Jun 2015
+8 more trials
DS
7 programs
5
2
CholestyraminePhase 42 trials
Olmesartan medoxomilPhase 41 trial
CS-8080Phase 11 trial
DS-1971aPhase 11 trial
DS-1971aPhase 11 trial
+2 more programs
Active Trials
NCT00796575Terminated16Est. Dec 2008
NCT02473627Completed18Est. Jul 2015
NCT02261376Completed48Est. Nov 2014
+5 more trials
Jazz Pharmaceuticals
2
1
RapydanPhase 41 trial
CMX001Phase 11 trial
CMX157Phase 11 trial
Active Trials
NCT00780182Completed24Est. Jan 2009
NCT01080820Completed36Est. Dec 2010
NCT00670696Withdrawn0
Genentech
3 programs
2
1
Fluticasone propionatePhase 41 trial
DasatinibPhase 1Small Molecule1 trial
MLDL1278APhase 1
Active Trials
NCT01398046Completed10Est. Feb 2014
NCT02476825Active Not Recruiting30Est. Oct 2026
S
2 programs
1
1
1.5% levofloxacin ophthalmic solutionPhase 41 trial
ParoxetinePhase 11 trial
Active Trials
NCT00879099Completed12Est. Jan 2010
NCT00703313Completed72
Rhythm Pharmaceuticals
1 program
1
SetmelanotidePhase 4Peptide1 trial
Active Trials
NCT05046132Completed77Est. Apr 2022
Amgen
1 program
1
leptinPhase 41 trial
Active Trials
NCT00121433Completed15Est. Dec 2004
Teva
132 programs
131
1
DR-1021Phase 31 trial
5 mg/500 mg Glipizide Metformin Hydrochloride TabletsPhase 11 trial
5 mg/500 mg METAGLIP™ TabletsPhase 11 trial
600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mLPhase 11 trial
Alendronate Sodium Tablets 70mgPhase 11 trial
+127 more programs
Active Trials
NCT00835497Completed40Est. Jun 2004
NCT00834587Completed40Est. Jun 2004
NCT00840840Completed48Est. Aug 2002
+156 more trials
M&
Merck & Co.RAHWAY, NJ
89 programs
84
2
Comparator: Varicella Zoster Virus VaccinePhase 3Vaccine1 trial
V110, pneumococcal vaccine polyvalentPhase 3Vaccine1 trial
ARQ 197Phase 11 trial
Activity Tracking WatchPhase 11 trial
Allyl IsothiocyanatePhase 11 trial
+84 more programs
Active Trials
NCT03942705Completed200Est. May 2021
NCT05340452CompletedEst. Oct 2013
NCT06675994Not Yet Recruiting80Est. Dec 2025
+111 more trials
Biogen
26 programs
24
1
BG00012Phase 32 trials
25G x 1" Needle AutoinjectorPhase 11 trial
AvonexPhase 11 trial
BG00012 Dose 1Phase 11 trial
BIIB014Phase 11 trial
+21 more programs
Active Trials
NCT02531009Withdrawn0Est. Mar 2017
NCT01313364Terminated80Est. Apr 2011
NCT01416207Completed24Est. Oct 2011
+27 more trials
AT
3
1
1
AG200-15Phase 31 trial
levonorgestrelPhase 1/21 trial
AG200-15Phase 11 trial
AG200-15Phase 11 trial
Ortho-CyclenPhase 11 trial
Active Trials
NCT01422135Completed24Est. Apr 2011
NCT01375946Completed24Est. Jun 2011
NCT01243580Completed36Est. Dec 2009
+2 more trials
Dynavax Technologies
1
2
HEPLISAVPhase 31 trial
HEPLISAV and/or PlaceboPhase 31 trial
SD-101Phase 11 trial
Active Trials
NCT00599001Completed26Est. Mar 2008
NCT02117934Completed8,374Est. Oct 2015
NCT01005407Completed2,452Est. May 2011
GC Biopharma
2 programs
1
Hantavax injectionPhase 31 trial
Omega- 3N/A1 trial
Active Trials
NCT05621083CompletedEst. Jan 2025
NCT02553837UnknownEst. Jul 2022
Regeneron
RegeneronTARRYTOWN, NY
14 programs
13
1
casirivimab+imdevimabPhase 2Monoclonal Antibody2 trials
Casirivimab+ImdevimabPhase 1Monoclonal Antibody1 trial
PozelimabPhase 1Monoclonal Antibody1 trial
PozelimabPhase 1Monoclonal Antibody1 trial
REGN10933+REGN10987Phase 12 trials
+9 more programs
Active Trials
NCT05181683Completed45Est. Jun 2022
NCT04940364Completed30Est. Jun 2022
NCT04601844Completed19Est. Jul 2021
+6 more trials
Ironwood Pharmaceuticals
1
IW-6118Phase 21 trial
7 g IspaghulaN/A1 trial
Active Trials
NCT01805999CompletedEst. Mar 2016
NCT01107236CompletedEst. Aug 2010
QT
Q TherapeuticsUT - Salt Lake City
2 programs
1
1
Lumentin® 44 Powder for oral foamPhase 21 trial
Blood stage parasitePhase 1/21 trial
Active Trials
NCT01055002CompletedEst. Aug 2010
NCT05781490CompletedEst. Feb 2023
AT
1
DihydrotestosteronePhase 1/21 trial
Active Trials
NCT00490022CompletedEst. Jan 2009
Galapagos
Galapagos2800 MECHELEN, Belgium
62 programs
62
100 mg GLPG1205Phase 11 trial
100 mg dose of [14C] GLPG0634Phase 11 trial
200 mg GLPG0634 as capsules, fastedPhase 11 trial
500 mg GLPG1837 as oral suspensionPhase 11 trial
GLPG0187Phase 11 trial
+57 more programs
Active Trials
NCT02143856Completed12Est. Jul 2014
NCT01820806Completed6Est. Apr 2013
NCT01915667Completed12Est. Sep 2013
+59 more trials
Corcept Therapeutics
21
14C-CORT125281Phase 11 trial
CORT118335 OralPhase 11 trial
CORT118335, 25 mgPhase 11 trial
CORT125134Phase 11 trial
CORT125134Phase 11 trial
+16 more programs
Active Trials
NCT03877952Completed6Est. Nov 2018
NCT03878264Completed12Est. Mar 2019
NCT03315338Completed143Est. Feb 2019
+18 more trials
Astellas
AstellasChina - Shenyang
19 programs
19
ASP015KPhase 15 trials
ASP0456Phase 11 trial
ASP1585Phase 11 trial
ASP1585Phase 11 trial
ASP1585Phase 11 trial
+14 more programs
Active Trials
NCT04143477Completed36Est. Dec 2020
NCT03660059Completed385Est. Nov 2021
NCT02760342Completed24Est. Jun 2016
+24 more trials

+132 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonListerine Clinical Solutions Teeth Strength
Johnson & JohnsonA
Johnson & JohnsonListerine Experimental Mouthwash
Johnson & JohnsonA
Johnson & JohnsonA
Johnson & JohnsonColgate Cavity Protection Toothpaste
Johnson & JohnsonA
PfizerMetformin

Showing 15 of 49 trials with date data

Clinical Trials (50)

Total enrollment: 5,569 patients across 50 trials

The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD)

Phase 4Unknown

A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)

Start: Dec 2025Est. completion: Nov 202778 patients
Phase 4Recruiting

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

Start: Oct 2025Est. completion: Oct 2027115 patients
Phase 4Recruiting

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Start: Aug 2025Est. completion: Sep 2027100 patients
Phase 4Recruiting

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

Start: Jun 2025Est. completion: Jun 202747 patients
Phase 4Recruiting

A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

Start: May 2025Est. completion: Jun 202775 patients
Phase 4Recruiting

Plan Development for Giving Teclistamab in the Outpatient Setting

Start: Nov 2024Est. completion: Oct 202615 patients
Phase 4Recruiting

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Start: Sep 2024Est. completion: Sep 2026734 patients
Phase 4Recruiting
NCT06136455Johnson & JohnsonListerine Clinical Solutions Teeth Strength

A Study to Investigate Salivary Flow and Potential of Hydrogen (pH) Following Use of Essential-Oil Containing Mouthwashes

Start: Nov 2023Est. completion: Nov 2023164 patients
Phase 4Completed

Positioning of Esketamine Treatment in the Real-world Management of Depression

Start: Oct 2023Est. completion: Jan 2026162 patients
Phase 4Recruiting
NCT06010758Johnson & JohnsonListerine Experimental Mouthwash

A Two-Week Study of an Anticavity Low pH Mouthwash

Start: Jul 2023Est. completion: Aug 2023163 patients
Phase 4Completed

Immune Spatial Features of Guselkumab Cutaneous Response

Start: Jul 2023Est. completion: Jun 202610 patients
Phase 4Recruiting

Effect of Biktarvy & Symtuza on microRNAs in HIV and Correlation With Weight Gain

Start: Mar 2023Est. completion: Mar 202530 patients
Phase 4Unknown
NCT05756673Johnson & JohnsonColgate Cavity Protection Toothpaste

A Study of Virtually Supervised Mouthwash and Interdental Brushes

Start: Feb 2023Est. completion: Oct 2023292 patients
Phase 4Completed

Home Based Daratumumab Administration for Patients With Multiple Myeloma

Start: Nov 2022Est. completion: May 202420 patients
Phase 4Completed

Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer

Start: Sep 2022Est. completion: Sep 20220
Phase 4Withdrawn
NCT05526586Johnson & JohnsonColgate Cavity Protection Toothpaste

A Twelve Week Study of Prototypes Mouth Rinses

Start: Aug 2022Est. completion: Dec 2022192 patients
Phase 4Completed

Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

Start: May 2022Est. completion: Feb 202319 patients
Phase 4Completed
NCT05600231Johnson & JohnsonLISTERINE COOL MINT Antiseptic Mouthwash

A Study of Virtually Supervised Mouth Rinses and Flossing

Start: Apr 2022Est. completion: Jul 2022284 patients
Phase 4Completed

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Start: Mar 2022Est. completion: Oct 2037295 patients
Phase 4Recruiting

A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease

Start: Dec 2021Est. completion: May 2025182 patients
Phase 4Completed

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

Start: Nov 2021Est. completion: Jul 202315 patients
Phase 4Terminated

Rapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)

Start: Sep 2021Est. completion: Apr 202475 patients
Phase 4Completed

Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Participants

Start: Aug 2021Est. completion: Apr 202277 patients
Phase 4Completed

A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Start: Jul 2021Est. completion: Oct 202353 patients
Phase 4Completed

The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients

Start: Apr 2021Est. completion: Feb 202315 patients
Phase 4Completed

A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

Start: Apr 2021Est. completion: Jul 2024183 patients
Phase 4Completed

Guselkumab Immunogenetics

Start: Mar 2021Est. completion: Jan 202525 patients
Phase 4Recruiting

Inflammation and Co-Infections in D²EFT

Start: Feb 2021Est. completion: Dec 20220
Phase 4Withdrawn

Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan

Start: Nov 2020Est. completion: Mar 2025100 patients
Phase 4Unknown

A Study of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

Start: Jul 2020Est. completion: Aug 2023103 patients
Phase 4Completed
NCT03794154PfizerCymbalta capsule

A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions

Start: Mar 2020Est. completion: Jun 20200
Phase 4Withdrawn
NCT03729284PfizerCymbalta Capsules

A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta

Start: Mar 2020Est. completion: Jun 20200
Phase 4Withdrawn

A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)

Start: Dec 2019Est. completion: Mar 202417 patients
Phase 4Completed

Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)

Start: Sep 2019Est. completion: Dec 20211 patients
Phase 4Terminated

A Study of Itraconazole in the Management of Superficial Fungal Infections in India

Start: Aug 2019Est. completion: Mar 202040 patients
Phase 4Terminated

A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion

Start: Jun 2019Est. completion: May 202375 patients
Phase 4Completed

A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent

Start: Jun 2019Est. completion: Jul 2022150 patients
Phase 4Completed
NCT03803371PfizerUltracet Tablets

Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets

Start: Mar 2019Est. completion: Jun 201960 patients
Phase 4Completed

A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

Start: Jan 2019Est. completion: Nov 2021100 patients
Phase 4Completed

A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)

Start: Dec 2018Est. completion: Jun 202078 patients
Phase 4Completed
NCT03711708PfizerZoloft Oral Solution

Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets

Start: Nov 2018Est. completion: Feb 201936 patients
Phase 4Completed
NCT03653741EisaiPerampanel 6 MG

Effects of Perampanel on Neurophysiology Test Perimeters

Start: Oct 2018Est. completion: Nov 202112 patients
Phase 4Completed

Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing Patients

Start: Feb 2018Est. completion: May 201857 patients
Phase 4Completed

Dolutegravir and Darunavir Evaluation in Adults Failing Therapy

Start: Nov 2017Est. completion: Oct 2023831 patients
Phase 4Unknown

A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA in Healthy Adult Women

Start: Sep 2017Est. completion: May 201870 patients
Phase 4Completed

Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

Start: May 2017Est. completion: May 2027297 patients
Phase 4Active Not Recruiting

A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants

Start: Apr 2017Est. completion: May 20178 patients
Phase 4Completed

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Start: Nov 2016Est. completion: May 201861 patients
Phase 4Terminated

An Efficacy and Safety Study of Infliximab Dose Escalation in Pediatric Participants With Inflammatory Bowel Disease

Start: Apr 2016Est. completion: Jul 201953 patients
Phase 4Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

12 late-stage (Phase 3) programs — potential near-term approvals
11 actively recruiting trials targeting 5,569 patients
30 companies competing in this space